Loading...
A Novel T Cell-Engaging Bispecific Antibody for Treating Mesothelin-Positive Solid Tumors
As mesothelin is overexpressed in various types of cancer, it is an attractive target for therapeutic antibodies. T-cell bispecific antibodies bind to target cells and engage T cells via binding to CD3, resulting in target cell killing by T-cell activation. However, the affinity of the CD3-binding a...
Na minha lista:
| Udgivet i: | Biomolecules |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7175222/ https://ncbi.nlm.nih.gov/pubmed/32143496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom10030399 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|